About

About the International Society for Mannosidosis & Related Diseases

Our Mission

ISMRD is the leading advocate for families worldwide affected by a Glycoprotein Storage Disease. Through partnerships built with medicine, science and industry, we seek to detect and cure these diseases, and to provide a global network of support and information.

    Our Story

    ISMRD was incorporated as the International Society for Mannosidosis & Related Diseases in Baltimore, Maryland, USA on March 10, 1999. Paul and Debora Murphy, parents of a child with Alpha-Mannosidosis, developed the organization to fill a void they perceived existed both for affected families and scientists and physicians with an interest in research and treatment modalities.

    ISMRD continues to seek a future in which children with Glycoprotein Storage Diseases can be detected early, treated effectively, and go on to live long, healthy and productive lives.

      It All Began with Taryn

      On August 3, 1984, Taryn was born to Paul and Debora Murphy. As time passed, Taryn was diagnosed with a very rare disease called Alpha-Mannosidosis. Very little was known about it at the time. When Taryn was 15, Paul and Debora founded the International Society for Mannosidosis and Related Diseases (ISMRD). Its mission was to help build more information about this disease and six others, collectively known as Oligosaccharide Storage Diseases.

      The strategy was to identify patients, form networks and encourage research. Today there are two therapies for Alpha-Mannosidosis: bone marrow transplants and enzyme replacement therapy. ISMRD now supports nine similar diseases which are grouped together as Glycoprotein Storage Diseases. To date there have been six international scientific and family conferences about them.

      As we celebrate Taryn’s 40th birthday in 2024, we would like to thank Taryn, Paul and Debora for starting ISMRD, which now represents all of the nine glycoprotein storage disorders.

      Taryn with roses at her 40th birthday
      Taryn with Cheesy bear

      Why Penguins?

      Like penguins in real life, our penguins show great adaptability to their harsh environment, manifested in the diseases that have afflicted their children. ISMRD’s penguins are learning to symbolically fly and overcome the disadvantages of genetics and the clinical symptoms that have ensued. Our penguins will eventually “fly” by finding treatments and cures for these diseases and, in the meantime, will find ways to support one another across nations and differences in language, religion and culture.

       

      Meet the Team

      Our Board of Directors

      Carolyn Paisley-Dew
      President, Australia

      Danielle Forsman
      Treasurer, USA

      Sarah Forsman
      Communications Officer, USA

      Darko Jamnik
      Board Member, Slovenia

      Hussain Peeran
      Board Member, USA

      Lama Khalil-Qashou
      Board Member, Saudi Arabia

      Laurel Gregier
      Board Member, USA

      Patricia Gribel
      Board Member, Brazil

      Tareq Qashou
      Board Member, Saudia Arabia

      Cagdas Canbolat
      Board Member, England

      Abby Melone
      Board Member, USA

      Mark Stark
      Board Emeritus, USA

      John Forman
      Board Emeritus, New Zealand

      Pam Tobey
      Board Emeritus, USA

      Jenny Noble
      Board Emeritus, New Zealand

      Our Advisory Board

      Dr. Steve Walkley

      Dr. Sara Cathey

      Dr. Alessandra D’Azzo

      Dr. Dag Malm

      Dr. Marc Patterson

      Dr. Richard Steet

      Dr. Charles Vite

      Dr. Thomas Braulke

      Dr. Amelia Morrone

      Dr. Enrico Moro

      Dr. Vish Koppaka

      Jenny Klein